Skip to main content
Clinical Trials/NCT03853174
NCT03853174
Completed
Not Applicable

Effect of Exercise Training on Inflammatory Mediators in COPD

Faculty of Medicine, Sousse1 site in 1 country28 target enrollmentJanuary 1, 2019
ConditionsCOPD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
Faculty of Medicine, Sousse
Enrollment
28
Locations
1
Primary Endpoint
Enzyme linked immunosorbent assay for serum cytokines levels change
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Chronic obstructive pulmonary disease (COPD) is widely spread all over the world. It is predicted to be the third leading cause of death by 2020[1]. COPD is a common, preventable treatable disease that is characterized by an airflow limitation which is not fully reversable[2].

Detailed Description

Chronic obstructive pulmonary disease (COPD) is widely spread all over the world. It is predicted to be the third leading cause of death by 2020. COPD is a common, preventable treatable disease that is characterized by an airflow limitation which is not fully reversable.Not only the long-term exposition to noxious particles and gases contributes to the development of COPD, but also so many others factors such as genetics and cigarette smoking. It has been shown that cigarettes are harmful and contributed to different extra pulmonary disorders. Indeed, it induced a systemic inflammation that was considered as a key process in the pathogenesis of COPD and triggered the activation of inflammatory cells and an abnormal increase of circulating cytokines such as CRP, interleukin (IL6), IL8, tumor necrosis factor alpha (TNF alpha) and leptin.

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
April 27, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Faculty of Medicine, Sousse
Responsible Party
Principal Investigator
Principal Investigator

Acheche Amal

PhD student

Faculty of Medicine, Sousse

Eligibility Criteria

Inclusion Criteria

  • COPD diagnosed by pulmonary function testing
  • Clinically stable
  • Abscence of other obstructive diseases
  • Signed written consent

Exclusion Criteria

  • Neuromuscular diseases -Severe psychiatric, neurologic or musculoskeletal conditions and /or instable--- --
  • cardiovascular diseases.
  • Contre-indications to physical therapy
  • Acute exacerbations a month before the intervention

Outcomes

Primary Outcomes

Enzyme linked immunosorbent assay for serum cytokines levels change

Time Frame: Baseline, 6 months

The interleukines were determined by ELISA assays with commercial kits

Study Sites (1)

Loading locations...

Similar Trials